Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The influenza hemagglutinin stem region is a highly conserved domain at the base of the hemagglutinin (HA) protein, protruding from the surface of the influenza virus. Unlike the immunodominant globular head, the stem fulfills essential biological functions: it anchors HA to the viral membrane and mediates the fusion of the viral and host cellular membranes during infection, a process triggered by low pH in the endosome[1][6][7]. The stem domain is structurally characterized by alpha-helical coils spanning the trimer interface, and contains the fusion peptide required for membrane merger[6]. The HA stem is a validated therapeutic target, underlying both broadly neutralizing antibody therapies and universal vaccine strategies; its high sequence conservation makes it suitable for cross-subtype targeting[7][8]. Mutations in the stem region modulate HA stability and therefore influence viral transmission, host range, and pathogenicity[2][3][4]. Promising interventions include rationally stabilized stem immunogens and monoclonal antibodies that inhibit fusion, offering potential to prevent or treat a broad spectrum of influenza infections[5][7][8].
Inhibition of viral entry by blocking membrane fusion[7][8] Stabilization of prefusion HA conformation to prevent structural changes required for infection[5][7][8] Targeting highly conserved epitopes to neutralize multiple influenza subtypes[7][8]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza hemagglutinin stem region (HA stem).